Kabonib 60 mg Tablet

Description

Kabonib 60 mg Tablet contains the active ingredient Cabozantinib, a potent multi-tyrosine kinase inhibitor used in the treatment of certain advanced cancers. It works by blocking multiple signalling pathways (including MET, VEGFR, AXL) which are involved in tumour growth, angiogenesis (blood vessel formation), and metastatic spread.It is indicated for use in adults with advanced kidney (renal cell) carcinoma, differentiated thyroid carcinoma, and in some cases of advanced liver (hepatocellular) carcinoma when other treatments have failed. Key Benefits: Targeted cancer therapy for challenging tumour types (kidney, thyroid, liver) Oral tablet formulation for convenient administration Helps to slow tumour progression and inhibit metastasis Option for patients when other therapies have not been effective Dosage & Administration:The usual recommended dose is 60 mg once daily, taken on an